GARY WINFREY: Open Payments
NPI 1396034526 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 11 companies in 2025. Trend: 2023 $473 · 2024 $337 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| TOLMAR, INC. | 2 | $30 |
| Eisai Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: Cologuard Collection Kit, Ozempic, MOUNJARO, JATENZO, Leqembi, OTEZLA, CAPVAXIVE, SHINGRIX.
Industry payments across FL — which companies pay providers there.
